Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Burden”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02773095
What this trial is testing

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Who this might be right for
Cardiovascular DiseaseDiabetes Type IIBreast Cancer+1 more
Boston University 966
Not applicableStudy completedNCT04406714
What this trial is testing

Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 4,318
Not applicableStudy completedNCT03165409
What this trial is testing

Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread

Who this might be right for
Melanoma
Bristol-Myers Squibb 1,828
Not applicableStudy completedNCT02050490
What this trial is testing

Effect of a Symptom Diary on Symptom Care and Symptom Burden in Patients Treated With Chemotherapy: a Before-and-after-study

Who this might be right for
NauseaVomitingPain+2 more
Universitaire Ziekenhuizen KU Leuven 236
Not applicableStudy completedNCT06204289
What this trial is testing

Effects of Nurse-led Supportive Care Programme on Caregiver Burden and Resilience of Family Caregivers

Who this might be right for
Nurse-led Supportive Care
Izmir Bakircay University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04145115
What this trial is testing

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

Who this might be right for
Astrocytoma, IDH-Mutant, Grade 4Diffuse GliomaGlioblastoma, IDH-Wildtype+1 more
National Cancer Institute (NCI) 37
Not applicableEnded earlyNCT01193036
What this trial is testing

Symptom Burden in Patients With Cancer- and Treatment-Related Skin Problems

Who this might be right for
Skin Cancer
M.D. Anderson Cancer Center 11
Not applicableStudy completedNCT02786524
What this trial is testing

Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy

Who this might be right for
Uterine Cervical NeoplasmsOvarian NeoplasmsGynecologic Neoplasms+4 more
University of Michigan 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Testing effectiveness (Phase 2)Study completedNCT01173692
What this trial is testing

Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.

Who this might be right for
Oropharynx Cancer
M.D. Anderson Cancer Center 47
Post-approval studies (Phase 4)UnknownNCT05855122
What this trial is testing

Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital of Soochow University 48
Not applicableStudy completedNCT04064151
What this trial is testing

A Research Study for Latina Women Undergoing Breast Cancer Treatment

Who this might be right for
Cancer-related Problem/ConditionQuality of LifeStress, Emotional
Northwestern University 51
Not applicableNot Yet RecruitingNCT06482931
What this trial is testing

Bleeding in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Medical Center Groningen 160
Not applicableStudy completedNCT07151820
What this trial is testing

A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients

Who this might be right for
Leukemia, Chronic Myeloid
Novartis Pharmaceuticals 2,546
Not applicableActive Not RecruitingNCT03794635
What this trial is testing

An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer

Who this might be right for
Metastatic CancerLocally Advanced CancerThoracic Cancer+3 more
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)UnknownNCT03492918
What this trial is testing

Pembrolizumab in Combination With Paclitaxel in the Hormone Receptor-positive Metastatic Breast Cancer With High Tumor Mutational Burden Selected by Whole Exome Sequencing: Korean Cancer Study Group Trial (KCSG BR20-16)

Who this might be right for
Metastatic Breast Cancer
Yonsei University 30
Not applicableEnrolling By InvitationNCT06937606
What this trial is testing

Decrease Caregiving Fatigue in Group Leaders of a Support Group for Women After Cancer

Who this might be right for
Caregiver Burden
Wuerzburg University Hospital 64
Not applicableLooking for participantsNCT06743035
What this trial is testing

Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

Who this might be right for
Polycythemia Vera
iOMEDICO AG 200
Testing effectiveness (Phase 2)Looking for participantsNCT05093231
What this trial is testing

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cambridge University Hospitals NHS Foundation Trust 20
Testing effectiveness (Phase 2)UnknownNCT04185831
What this trial is testing

A MolEcularly Guided Anti-Cancer Drug Off-Label Trial

Who this might be right for
Solid Tumor
Uppsala University Hospital 167
Next Page